Altimmune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.About ALT
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. Its lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.
ALT Key Statistics
Stock Snapshot
As of today, Altimmune(ALT) shares are valued at $2.08. The company's market cap stands at 403.62M, with a P/E ratio of -2.60.
On 2026-10-27, Altimmune(ALT) stock moved within a range of $2.04 to $2.15. With shares now at $2.08, the stock is trading +1.7% above its intraday low and -3.5% below the session's peak.
Trading activity shows a volume of 2.22M, compared to an average daily volume of 3.56M.
Over the past 52 weeks, Altimmune(ALT) stock has traded between a high of $6.44 and a low of $2.02.
Over the past 52 weeks, Altimmune(ALT) stock has traded between a high of $6.44 and a low of $2.02.
ALT News
...
Altimmune ( (ALT) ) has issued an announcement. On October 27, 2026, Altimmune announced the appointment of seasoned biotech executives Peter Greenleaf and Ale...
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.